Conexeu Sciences Inc. filed a Form S-1 registration statement on November 19, 2026, covering the resale of up to 7,733,722 shares of common stock by selling securityholders.
Key Highlights
- Total shares registered: Up to 7,733,722 shares of common stock are covered by this resale registration statement.
- October 2026 Private Placement: 1,416,667 shares were issued to purchasers in a private placement that closed on October 15, 2026.
- Warrants at $3.00: 1,416,667 additional shares are issuable upon exercise of $3.00 per share common stock purchase warrants issued in the October 2026 Private Placement.
- Warrants at $2.30: 4,355,388 shares are issuable upon exercise of outstanding $2.30 per share common stock purchase warrants.
- Exercised warrant shares: 545,000 shares were issued upon exercise by certain holders of the $2.30 Warrants prior to this filing.
- Last reported share price: On November 18, 2026, the last reported sale price of the company's common stock on the Nasdaq Capital Market was $2.355 per share.
- No company proceeds from resale: The company disclosed it will not receive any proceeds from the resale of shares by the selling securityholders, though it may receive proceeds if warrants are exercised for cash.
Conexeu Sciences S-1 Resale Registration: October 2026 Private Placement and Warrant Shares
Conexeu Sciences Inc. (NASDAQ:CNXU) filed a Form S-1 registration statement seeking to register for resale up to 7,733,722 shares of its common stock on behalf of selling securityholders. According to the filing, the company itself is not offering any shares for sale and will not receive proceeds from the selling securityholders' resale activity under this prospectus.
The filing identifies four categories of shares covered by the registration. First, 1,416,667 shares were issued directly to purchasers in the October 2026 Private Placement, which the filing states closed on October 15, 2026. Second, 1,416,667 shares are issuable upon exercise of $3.00 Warrants issued in that same private placement. Third, 4,355,388 shares are issuable upon exercise of $2.30 Warrants that were already outstanding. Fourth, 545,000 shares were issued upon exercise of $2.30 Warrants by certain holders prior to the filing date.
The prospectus states that selling securityholders anticipate offering shares at prevailing market prices on the Nasdaq Capital Market, at prices related to such prevailing market prices, or at negotiated prices. The company disclosed that it agreed to bear substantially all registration and resale expenses, other than selling commissions. No underwriter has been engaged to facilitate the sale. The registration statement had not yet been declared effective as of the filing date, and the prospectus noted that the information "is not complete and may be changed."
What Was Disclosed
Conexeu Sciences Inc. filed a Form S-1 to register up to 7,733,722 resale shares on behalf of selling securityholders, covering shares from its October 2026 Private Placement and from outstanding $3.00 and $2.30 common stock purchase warrants.



Please wait processing your request...